CCN2 and Hepatic fibrosis: For example, CTGF, a fibrosis-related cargo that we discussed in this review, has potential utility as a noninvasive biomarker of liver fibrosis because the levels of CTGF are substantially increased in fibrotic liver tissues or serum that were collected from human patients [73].